Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7935796 Monoclonal antibodies against ANGPTL3

Patent 7935796 was granted and assigned to Lexicon Pharmaceuticals, Inc. on May, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Lexicon Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

May 3, 2011

Patent Application Number

12001012

Date Filed

December 6, 2007

Patent Citations Received

US Patent 11840692 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

0

US Patent 11926660 Anti-ApoE antibodies

0

US Patent 11866709 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

0

US Patent 11834662 Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

0

US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression

0

Patent Primary Examiner

Patent abstract

Monoclonal antibodies that specifically bind to ANGPTL3 are provided. Monoclonal antibodies that neutralize at least one activity of ANGPTL3 are provided. Methods of treating a disorder of lipid metabolism using neutralizing monoclonal antibodies are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7935796 Monoclonal antibodies against ANGPTL3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.